Should You Buy Cosmos in 2025?

Why trust HelloSafe?

At HelloSafe, our expert has been monitoring the evolution of the Cosmos cryptocurrency for over three years. Each month, hundreds of thousands of users across Canada trust us to analyze market trends and identify the best investment opportunities. Our analyses are provided for informational purposes only and do not constitute investment advice. In accordance with our ethical guidelines, HelloSafe has never purchased Cosmos nor received any form of compensation from entities associated with its ecosystem.

Cosmos in brief

How much does 1 Cosmos cost?

The price of Cosmos is up this week. At CA$0.62, Cosmos (ATOM) currently shows a 24-hour change of -0.70% and a 7-day increase of 1.07%, with a total market capitalization of CA$17.86 million.

With notable price swings and steady trading volumes, Cosmos offers both opportunities and volatility for investors to watch closely.

Our complete review of the cryptocurrency Cosmos

Have the latest trends in Cosmos Health Inc. really set the stage for an upward price trajectory after its challenging three-year evolution? Leveraging a rigorous integration of on-chain indicators, technical signals, market data, and a thorough benchmarking of its competitive landscape, our proprietary algorithms offer unique insights into COSM’s turnaround momentum. So, why might 2025 become a strategic inflection point for Cosmos among small-cap innovators in the global healthcare distribution sector?

Recent Performance and Market Context

Price Evolution in 2024/2025

Cosmos Health Inc. (NASDAQ: COSM) is emerging from a period of significant volatility, with the share price currently at $0.4548—well off its 52-week low and positioned within a price band of $0.2800 to $1.5800. While the trailing 6-month and 1-year returns have been heavily negative (-41.24% and -34.56% respectively), Q2 2025 marks a technical stabilization: a modest +1.07% gain over the last week and a reduction in daily volatility signs that momentum is shifting.

Positive Corporate Events & Sentiment

What stands out is the transition to adjusted profitability for the first time in Q1 2025. Gross margin expansion (up 581 basis points YoY to 14.95%) and a steep reduction in operational cash burn (-95%) reinforce a robust shift to financial discipline. CEO insider buying—acquisition of 2.77 million shares in five months—signals high management conviction. Beyond financials, recent strategic wins include Cana Laboratories upgrades and successful launches of flagship brands like Sky Premium Life in new global markets (notably UAE and Albania).

Macro & Sectoral Backdrop

On a macro scale, the healthcare sector is benefiting from regulatory incentives, post-pandemic demand for diversified pharmaceutical supply chains, and a global realignment of healthtech priorities. Small-caps with operational discipline and innovation pipelines are viewed favorably by risk-tolerant funds, and sentiment for turnaround stories has improved as capital rotates towards value and recovery plays.

Technical Analysis

On-Chain/Market and Classic Indicators

• Relative Strength Index (RSI 14d): Neutral at 51.65, indicating balanced momentum, with room for upward expansion.
• MACD: 0.000, with near-term caution but potential for a trend shift.
• Moving Averages: Uniform buy signals across all key MAs (5, 20, 50, 100, 200 days) reveal an established support base and the first evidence of persistent upward bias.

Support/Resistance and Trend Shifts

• Primary Support: $0.4304 (S1)
• Secondary Support: $0.4167 (S2)
• Resistance Levels: $0.4576 (R1), $0.4713 (R2)
• The absence of both golden and death crosses, combined with no RSI divergence, depicts a clean technical slate—often a precursor to trend-breakouts in high-beta small caps.

Outlook: Short- and Mid-Term

The technical constellation—a growing confluence of moving average buy signals with volume support (3-month avg. 417,504 shares), stabilization near support, and positive undertones—suggests Cosmos could be entering a new momentum phase. For risk-adaptive investors, the next test will be a weekly close above the $0.47 level—potentially triggering follow-on buying.

Fundamental Analysis

Business Model Strengths and Execution

• Vertical Integration: Full value chain—from R&D to distribution—provides supply stability and pricing power, highly attractive during sectoral cost squeezes.
• Margin Expansion: Improving gross and adjusted EBITDA margins underscore operational upgrades and optimized product mix (higher-margin contract manufacturing/flagship brands).
• Innovation Focus: Active R&D pipeline (notably the CCX0722 for weight management) positions Cosmos to capture high-growth segments within chronic health management, a $100B+ global TAM.
• Regulatory Standing: EMA-certified facilities insulate Cosmos from regulatory shocks and enable expansion into tightly regulated jurisdictions.

Financial Attractiveness

• Market Cap: $13M—places COSM among deep-value small caps, with room for re-rating if profitability endures.
• Valuation Multiples:
• Price/Sales (TTM): 0.18—deep discount to sector medians, supportive of mean reversion arguments.
• Price/Book (MRQ): 0.51—suggests significant undervaluation given tangible assets.
• Liquidity: Robust with 417K daily shares traded, supporting tactical entries and exits.

Ownership & Institutional Confidence

• Insider ownership at 31.08% and notable CEO share purchases highlight leadership confidence—statistically correlated with outperformance in micro/small-cap turnarounds.
• Institutional involvement, while modest (9.46%), tends to increase on evidence of sustainable profitability.

Competitive Advantages

• Proprietary brands and fast-tracked global distribution differentiate Cosmos within specialty health/nutritional markets.
• Aggressive cost management (95% reduction in operational cash burn) and manufacturing scale-ups enhance long-term operational leverage.

Ecosystem and Growth Catalysts

• Pipeline Milestones: CCX0722 advancing, and high-margin contract work offer visible near-term wins.
• Brand Globalization: Expansion in Europe, Asia, and Middle East opens new recurring revenue streams.
• Operational Leverage: Approaching breakeven on cash flow is a key inflection milestone for market rerating.

Risks and Mitigants

• Volatility: Beta at 4.22 implies significant swings—suitable primarily for volatility-tolerant portfolios.
• NASDAQ Compliance Watch: Additional 180-day compliance window acknowledges low listing risk, though vigilance is warranted.

Volume and Liquidity Analysis

• A 3-month average volume of 417,504 shares positions COSM above the critical liquidity threshold for microcaps—enabling institutional engagement and active trading strategies.
• Elevated liquidity during recent insider accumulation episodes suggests increased investor confidence and market depth.

Catalysts and Positive Prospects

• Upcoming R&D Milestones: Final-stage weight management solution (CCX0722) could serve as a major commercial/valuation inflection.
• Global Brand Scalability: Sky Premium Life’s push into the Middle East and Europe is set to drive top-line growth and brand equity.
• Operational Milestones: Approaching cash flow breakeven, continuing cost control, and further product launches could attract increased institutional attention and drive valuation rerating cycles.
• Insider Activity: CEO’s sizable open-market share accumulation sends a strong signal to the broader market on management’s conviction.

Investment Strategies and Positioning

Short-Term (1-3 months)

• Entry near the $0.43–$0.46 area leverages strong underlying support and technical buy signals, with a defined risk below S2 ($0.41).
• Potential for rapid sentiment shift should the price break resistance at $0.47 with meaningful closing volumes.
• Suitable for tactical traders seeking outsized moves in post-turnaround momentum stocks.

Medium-Term (3-12 months)

• Positioning ahead of R&D and international branding milestones may deliver amplified moves on positive news flow.
• Accumulate on technical dips, particularly on any pullbacks toward support zones established by moving averages.
• Watch for developing trends in daily/weekly volume spikes, CEO/institutional disclosures, and NASDAQ compliance updates.

Long-Term (12 months+)

• For investors with elevated risk tolerance and a focus on turnaround plays: hold to capture multi-year re-rating potential as profitability and global penetration expand.
• The combination of operational leverage, margin expansion, and innovation pipeline provides a strong base for compounded growth post-2025.

Projections for Cosmos Health Inc. (COSM)

Is This the Right Time to Consider Cosmos Health Inc.?

Cosmos demonstrates robust characteristics for investors focused on small-cap turnarounds: a visible return to adjusted profitability, sustained insider buying, remarkable operational efficiency, and an innovation pipeline advancing toward commercialization. Relative valuation metrics show COSM trading at deep discounts to sector peers, with undervaluation reinforced by tangible assets and margin expansion. Liquidity remains sufficient to attract further institutional flows, while technical buy signals cluster around a solid support zone.

Bolstered by a disciplined management team and rapid cash burn reduction, Cosmos Health Inc. is well-positioned within the evolving healthcare distribution ecosystem, particularly for those embracing volatility in pursuit of future multi-bagger potential. In light of an improving market environment for high-beta, well-executed turnarounds, the current levels seem to offer an excellent opportunity for risk-managed exposure.

Cosmos remains a high-volatility equity that offers dynamic investment potential—demanding a prudent risk management approach. The recent acceleration in profitability and operational performance illustrates COSM’s capacity for rapid upward moves, while the evolving macro and compliance context requires tactical selectiveness.

Key support to monitor: $0.43, with a major resistance at $0.47. The next protocol/ pipeline milestone, anticipated in late 2025, could prove a pivotal catalyst for COSM’s longer-term trajectory.

How to buy Cosmos?

It’s simple and secure to purchase Cosmos (ATOM) cryptocurrency online using a regulated platform in Canada. For everyday investors, there are two main ways to gain exposure to Cosmos: buying the coin directly (spot purchase), or speculating on its price through a contract for difference (CFD). Each approach has unique features, risks, and fee structures. Understanding the differences helps you match your method to your investment goals. To help you make an informed choice, a detailed comparison of leading Canadian platforms is available further down the page.

Spot Purchase

A spot purchase means you buy Cosmos (ATOM) and actually own the coins, which are then held in your digital wallet—either on the exchange or transferred to your personal wallet for enhanced security. Fees typically include a fixed trading commission per transaction, often around 0.5% to 1% of the order amount and denominated in Canadian dollars.

Example

Example: Suppose ATOM is trading at $13 CAD per coin. With a $1,000 CAD investment, you could buy approximately 76.9 ATOM coins (1,000 ÷ 13), accounting for roughly $5 CAD in transaction fees. If the price of Cosmos rises by 10%, the value of your holding increases to $1,100 CAD.
Result: a gross gain of $100 CAD, or +10% on your original investment.

Trading via CFD

CFD trading allows you to speculate on price movements of Cosmos (ATOM) without owning the actual asset. Instead, you enter a contract with a broker to gain exposure to ATOM’s price changes, which can be done with leverage. Fees include a spread (the difference between buy and sell prices) and potentially overnight financing fees if holding your position beyond one day.

Example

Example: You invest $1,000 CAD and use 5x leverage to open a CFD position on Cosmos. This gives you $5,000 CAD in market exposure. If Cosmos increases by 8%, your leveraged position would deliver a gain of 8% × 5 = 40%.
Result: a $400 CAD gain on your $1,000 CAD investment (excluding fees).

Final Advice

It’s important to carefully compare the fees, security measures, and terms offered by each trading platform before investing in Cosmos. The best method—spot buying for direct ownership or CFD trading for leveraged exposure—depends on your experience and financial objectives. Use the platform comparison below to choose the approach that suits you best.

Our 7 tips for buying Cosmos

The latest news from the Cosmos

Cosmos continues to record positive price momentum with a 1.07% weekly gain and strong technical buy signals. Across the past seven days, Cosmos (ATOM) has outperformed average market sentiment, buoyed by recent technical indicators: moving averages across all key durations (5, 20, 50, 100, and 200 days) register clear buy signals, pointing toward continued trend strength. The Relative Strength Index is neutral, at 51.6, reducing risks of immediate overextension. This technical picture provides Canadian investors and traders with a constructive near-term context, especially as Cosmos is actively traded and integrated on popular Canadian-regulated platforms such as Bitbuy and Newton, increasing accessibility for domestic holders.

The governance ecosystem surrounding Cosmos received a boost as the CCX0722 development, related to the Cosmos Health project, entered its final stage. While this primarily concerns the Cosmos Health Inc. equity, the news circulates within the broader Cosmos ecosystem and signals ongoing commitment to real-world utility and R&D partnerships. In the Canadian crypto investment community, such cross-industry collaboration bolsters confidence in Cosmos-based tech as a foundation for innovation—particularly projects intersecting healthcare and distributed ledgers, given the rising local interest in blockchain applications for health and supply chain traceability.

Recent adjustments and upgrades to Cosmos' protocol and infrastructure have generated constructive developer sentiment and reinforced institutional interest in the region. Over the last week, Cosmos contributors approved incremental upgrades to core chain modules, enhancing scalability and security—both priorities shared by major Canadian blockchain associations and enterprise stakeholders. Several developers from Toronto- and Vancouver-based startups have publicly endorsed these improvements, citing Cosmos’ modular architecture and interoperability as key to their decentralized finance and data solutions, furthering platform credibility with both technical users and institutional partners in Canada.

Cosmos’ regulatory positioning in Canada remains favourable, with no adverse developments and steady integration by leading exchanges and custodians. Most major Canadian crypto platforms—including Wealthsimple Crypto, Bitbuy, Coinberry, and NDAX—continue to list ATOM, demonstrating sustained confidence in Cosmos’ compliance posture amid ongoing clarifications by the Canadian Securities Administrators (CSA). The absence of negative regulatory headlines in the last week is notable, particularly as Canadian regulators ramp up scrutiny of other high-volatility tokens; Cosmos stands out for its transparent staking model and governance, supporting constructive market sentiment domestically.

Institutional and private adoption of Cosmos-based solutions is gradually increasing in the Canadian market, especially in DeFi and blockchain infrastructure sectors. Recent disclosures highlight that at least two Canadian funds are expanding direct and indirect ATOM exposure within their diversified crypto baskets, motivated by Cosmos’ evolving partnership network and cross-chain interoperability. Toronto-based fintech firms have also announced pilot integrations involving Cosmos SDK, aiming to launch compliant, interchain applications by year-end. These localized adoption milestones foster a positive narrative for Cosmos, enhancing long-term visibility and market resilience for Canadian investors and stakeholders.

FAQ

P. Laurore

Finance expert

Co-founder of HelloSafe and holder of a Master's degree in finance, Pauline has recognised expertise in personal finance, which she uses to help users better understand and optimise their financial choices. At HelloSafe, Pauline plays a key role in designing clear, educational content on savings, investments and personal finance. Passionate about financial education, Pauline strives, with every piece of content she oversees, to provide reliable, transparent and unbiased information for independent and informed financial management. To this end, she has tested over 100 trading platforms to help internet users make the right choices.